Searched for
OLIVIER BRANDICOURT
Indian pharma majors weigh bids for Sanofi’s $2 billion European generics businessThe portfolio of acute, chronic and oncology products could fetch a valuation of $1.5-2 bn, making it among the largest outbound transactio...- Sanofi and Regeneron's eczema drug gets FDA approvalThe FDA approved Dupixent (dupilumab), is the first targeted biologic therapy for adults with moderate-to-severe atopic dermatitis.
- Pfizer to internally split its generic, branded drugs operationsPharma giant Pfizer Inc today said it plans to internally separate operations into three segments.
- Will achieve our ambitious economic agenda by elections: FMFM has assured global investors that their concerns over India's economy will be put to rest and the govt will achieve its " economic agend...
Load More